In unpaired samples, the expression levels of COL5A1 and LOXL1 were significantly higher in thyroid cancer than in normal tissues (505 cancer and 59 normal samples), and LYSMD3 levels were significantly lower in thyroid cancer (Figure S3). Here, LOXL1 is linked to thyroid gland carcinoma.